News

Bavarian Nordic Reports Better Than Expected Preliminary Financial Results for 2022

All-time high revenues and EBITDA profitability for 2022COPENHAGEN, Denmark, January 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) today reported…

1 year ago

ONWARD Announces Participation at Upcoming Events

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Jan. 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD),…

1 year ago

Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023

-- China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant…

1 year ago

CLINUVEL Trial Results Show Drug Reduces DNA Damage

Results in “children of the moon” disorder have implications for populations at highest risk of skin cancerMELBOURNE, Australia, Jan. 16,…

1 year ago

Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis

During the opentrial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at…

1 year ago

Entrepreneur Maricela Cortez Launches Bella Glam Academy for Aspiring Beauty Professionals

LAS VEGAS, NEVADA, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Self-Made female entrepreneur, Maricela Cortez is the Founder and CEO of…

1 year ago

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting  Trial Data Shows…

1 year ago

Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.

NEW YORK and PROVIDENCE, R.I., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special…

1 year ago

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),…

1 year ago

AnaptysBio Announces Stock Repurchase Plan

SAN DIEGO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative…

1 year ago